Market valued at $46.59B in 2024, projected 7.31% CAGR growth driven by bio-based adoption, detergent demand, and sustainable ingredient regulatory mandates. Industrial surfactants enable cleaning and ...

Coordinating the "two overall situations" is an important manifestation of the standpoints, viewpoints, and methods that run through Xi Jinping Thought on Socialism with Chinese Characteristics for a ...

"The recommendations for the 15th Five-Year Plan are the blueprint for China's economic and social development over the next ...

WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company ...

The Lebanese Army is preparing the national security strategy that President Joseph Aoun had pledged to devise in his inaugural speech, a media report said.The army is preparing it through “a ...

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, and WuXi Biologics (2269.HK), a leading ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

FAIR OAKS RANCH — Fair Oaks Ranch has begun the formulation of its 2026 Strategic Plan, designed to incorporate the ...

Market valued at $16.86B in 2024, projected 4.20% CAGR growth driven by VOC regulation compliance, bio-based adoption, ...

HONG KONG, HONG KONG , HONG KONG, January 21, 2026 /EINPresswire.com/ -- As skincare science rapidly evolves toward ...

SHANGHAI, TAIPEI and SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for ...

The Nanoparticle Contract Manufacturing market offers opportunities in pharmaceuticals, biotech, and advanced materials, driven by demand for complex nanoparticle formulations. CMOs enhance ...